Universe Pharmaceuticals Inc (UPC)

Name: Universe Pharmaceuticals Inc (UPC) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Universe Pharmaceuticals Inc (UPC)

Stock Card

$4.03

$-0.30 (-6.93%)

As on 04-Sep-2026 19:52EDT

Market cap

$3 Mln

Revenue (TTM)

$-- Mln

P/E Ratio

P/B Ratio

0.1

Div. Yield

0 %

Value Research Rating

Quality Score

Growth Score

Valuation Score

Momentum Score

Know more

Explore 5 star rated stocks

Universe Pharmaceuticals Inc (UPC) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 3.80 High: 4.36

52 Week Range

Low: 2.00 High: 17.96

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$-- Mln
ROE

-0 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

0.3
Debt to Equity

0.2
Book Value

$16037
EPS

$-1049.2
Face value

--
Shares outstanding

631,761

6 Years Aggregate

CFO

$21.53 Mln

EBITDA

$35.40 Mln

Net Profit

$19.13 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Universe Pharmaceuticals Inc (UPC)	5.8	-37.8	17.2	7.5	-43.3	-54.7	--
BSE Sensex^*	-10.1	-3.6	2.5	-5.7	4.9	5.5	10.1
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 04-Sep-2026 | *As on 07-Sep-2026 | #As on 26-Oct-2023

Company	2025	2023	2022
Universe Pharmaceuticals Inc (UPC)	524.6	-76.9	-11.3
S&P Small-Cap 600	4.0	13.9	-17.4
BSE Sensex	9.1	18.7	4.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Universe Pharmaceuticals Inc (UPC)	4.0	2.7	17.9	-3.7	--	-7.2	--	0.1
Aptorum Group Limited Class A - ADR	8.4	0.6	1.0	-5.7	0.0	-49	--	0.3
Bon Natural Life (BON)	1.2	11.8	18.7	-2.0	25.4	-3.9	--	0.2
Theravance Biopharma (TBPH)	17.1	886.8	104.3	53.8	61.6	18.4	16.4	3.1

Shareholding Pattern

View Details

About Universe Pharmaceuticals Inc (UPC)

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common... chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. It also provides guben yanling, shenrong weisheng, and quanlu pill; yangxue danggui and qiangli pipa syrup; wuzi yanzong oral, fengtong medicinal, shenrong medicinal, qishe medicinal, fengshitong medicinal, and shiquan dabu medicinal liquor; paracetamol granule for children; and isatis root granule. In addition, the company distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. It primarily serves pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is headquartered in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited. Read more

CEO & Chairman

Mr. Gang Lai
CEO & Chairman

Mr. Gang Lai
Headquarters

Ji'An
Website

https://www.universe-pharmacy.com

FAQs for Universe Pharmaceuticals Inc (UPC)

What is the current share price of Universe Pharmaceuticals Inc (UPC) Today?

The share price of Universe Pharmaceuticals Inc (UPC) is $4.03 (NASDAQ) as of 04-Sep-2026 19:52 EDT. Universe Pharmaceuticals Inc (UPC) has given a return of -43.25% in the last 3 years.

What is the current PB & PE ratio of Universe Pharmaceuticals Inc (UPC)?

Since, TTM earnings of Universe Pharmaceuticals Inc (UPC) is negative, P/E ratio is not available.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	0.00	0.00
2024	0.00	0.00
2023	0.00	0.00
2022	-1.41	0.26
2021	4.75	0.91

What is the 52 Week High and Low of Universe Pharmaceuticals Inc (UPC)?

The 52-week high and low of Universe Pharmaceuticals Inc (UPC) are Rs 17.96 and Rs 2.00 as of 08-Sep-2026.

What is the market cap of Universe Pharmaceuticals Inc (UPC)?

Universe Pharmaceuticals Inc (UPC) has a market capitalisation of $ 3 Mln as on 04-Sep-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in Universe Pharmaceuticals Inc (UPC)?

Before investing in Universe Pharmaceuticals Inc (UPC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.